RADNOR, Pa. (AP) _ Marinus Pharmaceuticals Inc. (MRNS) on Monday reported a loss of $11.1 million in its third quarter.
The Radnor, Pennsylvania-based company said it had a loss of 27 cents per share.
Marinus Pharmaceuticals shares have dropped 38 percent since the beginning of the year. The stock has dropped 16 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS